Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report

被引:126
作者
Akbani, Rehan [1 ]
Becker, Karl-Friedrich [2 ]
Carragher, Neil [3 ]
Goldstein, Ted [4 ]
de Koning, Leanne [5 ]
Korf, Ulrike [6 ]
Liotta, Lance [7 ]
Mills, Gordon B. [1 ]
Nishizuka, Satoshi S. [8 ]
Pawlak, Michael [10 ]
Petricoin, Emanuel F. [7 ]
Pollard, Harvey B. [9 ]
Serrels, Bryan [3 ]
Zhu, Jingchun
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Tech Univ Munich, D-80290 Munich, Germany
[3] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh, Midlothian, Scotland
[4] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA
[5] Inst Curie, Paris, France
[6] German Canc Res Ctr, Heidelberg, Germany
[7] George Mason Univ, Fairfax, VA 22030 USA
[8] Iwate Med Univ, Morioka, Iwate 020, Japan
[9] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[10] Nat & Med Sci Inst, Reutlingen, Germany
关键词
PARAFFIN-EMBEDDED TISSUES; HUMAN BREAST-CANCER; PATHWAY-ACTIVATION; CELL-LINES; MICROARRAY ANALYSIS; PROTEOMIC ANALYSIS; MEMBRANE-PROTEINS; SYSTEMS-ANALYSIS; DRUG DISCOVERY; BIOMARKER;
D O I
10.1074/mcp.O113.034918
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Reverse phase protein array (RPPA) technology introduced a miniaturized "antigen-down" or "dot-blot" immunoassay suitable for quantifying the relative, semi-quantitative or quantitative (if a well-accepted reference standard exists) abundance of total protein levels and post-translational modifications across a variety of biological samples including cultured cells, tissues, and body fluids. The recent evolution of RPPA combined with more sophisticated sample handling, optical detection, quality control, and better quality affinity reagents provides exquisite sensitivity and high sample throughput at a reasonable cost per sample. This facilitates large-scale multiplex analysis of multiple post-translational markers across samples from in vitro, preclinical, or clinical samples. The technical power of RPPA is stimulating the application and widespread adoption of RPPA methods within academic, clinical, and industrial research laboratories. Advances in RPPA technology now offer scientists the opportunity to quantify protein analytes with high precision, sensitivity, throughput, and robustness. As a result, adopters of RPPA technology have recognized critical success factors for useful and maximum exploitation of RPPA technologies, including the following: preservation and optimization of pre-analytical sample quality, application of validated high-affinity and specific antibody (or other protein affinity) detection reagents, dedicated informatics solutions to ensure accurate and robust quantification of protein analytes, and quality-assured procedures and data analysis workflows compatible with application within regulated clinical environments. In 2011, 2012, and 2013, the first three Global RPPA workshops were held in the United States, Europe, and Japan, respectively. These workshops provided an opportunity for RPPA laboratories, vendors, and users to share and discuss results, the latest technology platforms, best practices, and future challenges and opportunities. The outcomes of the workshops included a number of key opportunities to advance the RPPA field and provide added benefit to existing and future participants in the RPPA research community. The purpose of this report is to share and disseminate, as a community, current knowledge and future directions of the RPPA technology.
引用
收藏
页码:1625 / 1643
页数:19
相关论文
共 115 条
  • [1] A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease
    Addona, Terri A.
    Shi, Xu
    Keshishian, Hasmik
    Mani, D. R.
    Burgess, Michael
    Gillette, Michael A.
    Clauser, Karl R.
    Shen, Dongxiao
    Lewis, Gregory D.
    Farrell, Laurie A.
    Fifer, Michael A.
    Sabatine, Marc S.
    Gerszten, Robert E.
    Carr, Steven A.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (07) : 635 - U119
  • [2] Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer
    Agarwal, Roshan
    Gonzalez-Angulo, Ana-Maria
    Myhre, Simen
    Carey, Mark
    Lee, Ju-Seog
    Overgaard, Jens
    Alsner, Jan
    Stemke-Hale, Katherine
    Lluch, Ana
    Neve, Richard M.
    Kuo, Wen Lin
    Sorlie, Therese
    Sahin, Aysegul
    Valero, Vicente
    Keyomarsi, Khandan
    Gray, Joe W.
    Borresen-Dale, Anne-Lise
    Mills, Gordon B.
    Hennessy, Bryan T.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (11) : 3654 - 3662
  • [3] Proteomic Biomarkers for Blast Neurotrauma: Targeting Cerebral Edema, Inflammation, and Neuronal Death Cascades
    Agoston, Denes V.
    Gyorgy, Andrea
    Eidelman, Ofer
    Pollard, Harvey B.
    [J]. JOURNAL OF NEUROTRAUMA, 2009, 26 (06) : 901 - 911
  • [4] Collecting and organizing systematic sets of protein data
    Albeck, John G.
    MacBeath, Gavin
    White, Forest M.
    Sorger, Peter K.
    Lauffenburger, Douglas A.
    Gaudet, Suzanne
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (11) : 803 - 812
  • [5] High Resolution Mapping of the Cardiac Transmural Proteome Using Reverse Phase Protein Microarrays
    Anderson, Troy
    Wulfkuhle, Julia
    Petricoin, Emanuel, III
    Winslow, Raimond L.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2011, 10 (07)
  • [6] Improved reproducibility of reverse-phase protein microarrays using array microenvironment normalization
    Anderson, Troy
    Wulfkuhle, Julia
    Liotta, Lance
    Winslow, Raimond L.
    Petricoin, Emanuel, III
    [J]. PROTEOMICS, 2009, 9 (24) : 5562 - 5566
  • [7] Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
    Araujo, Robyn P.
    Liotta, Lance A.
    Petricoin, Emanuel F.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (11) : 871 - 880
  • [8] Multilayers of hydrogels loaded with microparticles: a fast and simple approach for microarray manufacturing
    Bally, Marta
    Voros, Janos
    Takeuchi, Shoji
    [J]. LAB ON A CHIP, 2010, 10 (03) : 372 - 378
  • [9] Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis
    Belluco, C
    Mammano, E
    Petricoin, E
    Prevedello, L
    Calvert, V
    Liotta, L
    Nitti, D
    Lise, M
    [J]. CLINICA CHIMICA ACTA, 2005, 357 (02) : 180 - 183
  • [10] Berg D, 2011, METHODS MOL BIOL, V785, P109, DOI 10.1007/978-1-61779-286-1_8